Canadian Imperial Bank of Commerce (CIBC) has filed a pricing supplement for $1 million in autocallable contingent coupon barrier notes linked to the iShares Russell 2000 ETF. This filing, made on November 9, 2026, is significant as it showcases CIBC's strategy to diversify its financial offerings in the competitive commercial banking sector.
The notes will provide quarterly contingent coupon payments of $25.20 per $1,000 principal amount, equivalent to 10.08% per annum, but only if the closing price of the underlying ETF meets certain conditions. This innovative product is part of CIBC's ongoing efforts to enhance its product portfolio and attract more investors.
Background
Canadian Imperial Bank of Commerce, listed under the ticker symbols CM on the NYSE and CNDIF on the OTC, operates primarily in the commercial banking sector (SIC 6029). The bank is headquartered at 81 Bay Street, Toronto, Ontario, and is known for its diverse range of financial services.
What the Filing Says
The filing indicates that the notes will be issued in minimum denominations of $1,000 and will not be listed on any securities exchange. It states, “The notes are unsecured obligations of the Bank and any payments on the notes are subject to the credit risk of the Bank.” This highlights the risks associated with investing in these notes.
Impact
This offering may attract a variety of investors looking for exposure to the performance of the iShares Russell 2000 ETF while receiving potential coupon payments. However, the contingent nature of these payments means that investors should be mindful of the risks involved, particularly the credit risk associated with CIBC.
What's Next
The notes are set to be delivered in book-entry form through The Depository Trust Company on November 12, 2026, against payment in immediately available funds. Further details regarding the performance of the notes will likely be shared in subsequent filings.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










